Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Precision Oncogenomics|August 29, 2025
Identifying Drug Combination Strategies for <i>ZMYM2: FGFR1</i> Fusion Positive LeukemiaAriane Huang, Sofia R Beer, Christopher A Eide, et al.Blood|April 22, 2020
Discovery and characterization of targetable NTRK point mutations in hematologic neoplasmsSunil K Joshi, Kristin Qian, William H Bisson, et al.Cell Reports. Medicine|December 30, 2025
CDK4/6 inhibition overcomes venetoclax resistance mechanisms with enhanced combination activity in acute myeloid leukemiaMelissa L Stewart, Jessica Gibbs, Kevin Watanabe-Smith, et al.Haematologica|February 13, 2025
Oncogenic <i>NTRK3</i> mutations exhibit differential sensitivity to tropomyosin receptor kinase inhibitors in patients with acute myeloid leukemiaSunil K Joshi, Ariane Huang, Janét Pittsenbarger, et al.Blood Cancer Discovery|September 12, 2023
Clinical Correlates of Venetoclax-Based Combination Sensitivities to Augment Acute Myeloid Leukemia TherapyChristopher A Eide, Stephen E Kurtz, Andy Kaempf, et al.Pageof 1